Summary
next put in cold oxygenized Krebs-Ringer solution (composition in mmol/liter: NaCl 119, 1 KCl 4.7, NaH 2 PO 4 1.2, MgSO 4 1.17, NaHCO 3 24, CaCl 2 2.5, glucose 5.5, and EDTA 0.034).
2
A small intramural coronary arteriole with an outer diameter between 150-200 µm was 3 prepared in situ from a terminal branch of the left anterior descendent coronary artery, as 4 described earlier (Nadasy et al. 2001) . The excised vessel segments had more than 2.0 mm 5 length to maintain the physiological cylindrical shape. They were cannulated at both ends 6 using microcannulas with outer diameters around 130 µm, and mounted in a glass-bottomed 7 organ bath (Experimetria LTD), then axially extended by 10 %, to simulate the in vivo axial 8 extension ratio. Artery segments were pressurized intraluminally by servo-controlled pumps 9 (Living Systems). The bath was thermostated at 37 o C, and bubbled with a gas mixture of 5% 10 CO 2 , 20% O 2 and 75% of N 2 , keeping the pH at 7.4. During incubation, continuous 11 superfusion was ensured at a rate of 2.8 ml/min, whereas the bath volume was 12.0 ml. The hydrochloride, nitro-L-arginine methyl ester hydrochloride (L-NAME), bradykinin acetate
17
(purity of all chemicals over 98%) and quercetin hydrate (purity over 95%)) were purchased 18 from Sigma-Aldrich. 
Ex vivo protocols

20
To study the biomechanical properties of coronary resistance artery segments, two 21 protocols were used. In the first series of experiments, arteries from 12 quercetin-treated 22 animals and 10 control rats were taken and incubated in nKR solution at 50 mmHg 23 intraluminal pressure for 30 minutes. Arteries develop spontaneous tone under these 24 conditions. A pressure diameter curve was next determined by raising the pressure from 10 to 100 mmHg in 10 mmHg steps with a 3-minute incubation at each pressure. After a 10-minute 1 rest the original diameter was restored, and we added norepinephrine to the bath (final 2 concentration 10 µmol/liter), incubated the vessel for 10 minutes and pressure diameter 3 curves were repeatedly recorded. Without washout, we added 10 µmol/liter acetylcholine, 4 incubated for 10 minutes, and repeated the pressure diameter curve. 100 µmol/liter L-NAME 5 was next added to block NO synthesis. After 20 minutes of incubation, a pressure diameter 6 curve was taken again. To test reproducibility, a washout with nKR solution was made, 7 followed by incubation for 20 minutes. Vessels with spontaneous tone differing from the 8 original by more than 5% at this point were rejected. Finally, the superfusion was changed to to 0.3865, p=0.004).
13
We found a slight but significant reduction in vasodilatory response to 10 µmol/liter 
18
Some limitation of our study seems to be the precise dosage of quercetin. Taking into 19 consideration of the long animal treatment period, we choose the safer dosage by drinking 20 water instead of gavage. In both groups, 3 animals were kept in a cage to minimize non-21 specific stress. With standardizing the environment, we ensured standard and average water 22 consumption during treatment, which provided a fairly standardized quercetin intake.
23
In conclusion, chronic administration of quercetin to rats in dietetically real amounts induced NO-mediated dilation) did not differ between the two groups, whereas quercetin-20 treated segments showed higher basal NO dilation activity using up a higher portion of that 21 maximum capacity under basal conditions. 
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